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How Can Laboratories Help Their Hospital Decrease Readmission Rates for Heart Failure Patients?

**Eugenio Zabaleta^1^, John Burgess^1^, Kay Truax^2^, Michael Patterson^3^**

^1^Departments Laboratory, ^2^Patient Education, and ^3^Administration, MedCentral Health System, Mansfield, OH. E-mail: <ezabaleta@medcentral.org>

**CONTENT**

Starting third quarter of 2012 hospitals will experience decreased Medicare reimbursement for all Medicare discharges when their readmission rates are higher than expected according the Hospital Readmissions Reduction Program. In response MedCentral Health system developed heart success, which is a program to assist patients with heart failure (HF) to avoid readmission to the hospital. As well, MedCentral utilizes Information technology (IT) to help identify all HF patients that could benefit with this program.

**TECHNOLOGY**

To respond to the new health-care challenges, MedCentral has decided to use a Laboratory Decision Support Software called RippleDown^®^ (from Pacific Knowledge Systems) to help identify all HF patients that could benefit with this program. Within this software, rules were developed for the purpose of stratifying patients according to their BNP and Troponin results (Circulation 2003; 108; 833-838). Also, this software will automatically communicate this information to the heart success personnel with minimal obstruction to clinical operation.

**DESIGN**

Since mid-October 2011, MedCentral Laboratory is able to perform risk stratification on every inpatient who has a BNP test done (BNP is the trigger). Once the risk is calculated, the result will be sent via E-mail with patient demographic information, risk calculation, and other laboratory data to the heart success personnel to prioritize patient management.

**RESULTS**

The US national heart failure re-admission rate is 24.8% and can be as high as 40% according to CMS (data from 2011). MedCentral hospital rate for people not enrolled in the heart success project is 26.7%, whereas it is 4% for the enrolled patients. This project went live on October 2011 and since then, the hospital average of HF re-admission rate is 20% or below (20.0% in October, 13.3% in November, and 16.1% in December). No data are available for 2012.

**CONCLUSIONS**

Even though most of the patients recruited for heart success are through physician referrals, the automated to Congestive Heart Failure (CHF) patient risk stratification project serves as a safety net for identifying those patients recently diagnosed with CHF or those who are not referred, or for those not treated in our main hospital.

Using Camera Systems to Read Entire Batches of Barcodes and More

**Lyman T. Garniss**

Partners Healthcare Systems -- IT, Massachusetts General Hospital, Boston, MA. E-mail: <LGarniss@partners.org>

**CONTENT**

Massachusetts General Hospital (MGH) Pathology Service is now using 2-D barcodes on all cassettes and slides. We are also tracking and routing these materials using Sunquest CoPath SMART. In some areas, it is desirable for patient safety and for workflow efficiency to scan entire batches of cassettes and/or slides instead of scanning individual assets.

**TECHNOLOGY**

The technology to accomplish this project included A Cognex industrial camera system with software that enables the identification and reading of 2-D barcodes. The Sunquest CoPath SMART system, unique asset identifiers for specimen cassettes and slides encoded on 2-D barcodes; Boston Workstation scripting tools, and an enclosure created by Machine Vision Consulting.

**DESIGN**

A rack of barcodes cassettes or a folder of slides is loaded into the camera enclosure. The rack or folder activates a switch in the enclosure, the system is activated turning on the lights, and the picture is taken. The picture is transferred to a computer, analysis is performed on the picture and the barcodes and a list of asset numbers is produced and sent to a file.

**RESULTS**

The file is then read by a Boston WorkStation script and then checked against the Sunquest CoPath database to ensure all specimens are together (none are missing) and the script also "checks" the assets out of the area in the tracking system. The system can complete the entire process of reading, checking, and updating the CoPath database on 78 cassettes in 2 min. Doing this manually takes a human over 10 min and does not allow for ensuring that all cassettes that should be together are together.

**CONCLUSION**

Batching reading of pathology assets (cassettes and slides) using an industrial camera system increases patient safety and allows for faster throughput of specimen processing when using tracking and routing software.

Clinical Genomicist Workstation

**Rakesh Nagarajan^1^, Mukesh K. Sharma^1^, Joshua Phillips^2^, Saurabh Agarwal^2^, Wesley S. Wiggins^2^, Savita Shrivastava^1^, Sunita B. Koul^1^, Madhurima Bhattacharjee^1^, Caerie D. Houchins^1^, Raghavendra R. Kalakota^1^, Bijoy George^1^, Rekha R. Meyer^1^, David H. Spencer^1^, Christina M. Lockwood^1^, TuDung T. Nguyen^1^, Eric J. Duncavage^1^, Hussam Al-Kateb^1^, Catherine E. Cottrell^1^, Suhasini Godala^2^, Ravi T. Lokineni^2^, Sameer M. Sawant^2^, Vasudev Chatti^2^, Suresh Surampudi^2^, Raja Rao Sunkishala^2^, Ramakant Darbha^2^, Sharath Macharla^2^, Jeffrey D. Milbrandt^3^, Herbert W. Virgin^1^, Robi D. Mitra^3^, Richard D. Head^3^, Shashikant Kulkarni^1^, Andrew Bredemeyer^1^, John D. Pfeifer^1^, Karen Seibert^1^**

^1^Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO, ^2^SemanticBits LLC, Herndon, VA, ^3^Department of Genetics, Washington University in St. Louis, St. Louis, MO. E-mail: <rakesh@wustl.edu>

**CONTENT**

The use of NextGen Sequencing clinically necessitates the need for informatics tools that support the complete workflow from sample accessioning to data analysis and reporting. To address this need, we have developed Clinical Genomicist Workstation (CGW).

**TECHNOLOGY**

Apache 2, Tomcat 6, Grails 2.0, Spring 3.1, Drools 5.2, YUI 2, jQuery 1.7, HTML5, Groovy 1.8, FreeMarker 2.3, Java 6, Oracle Database 11g, Red Hat Enterprise MRG 7.6.3, Integrated Genomics Viewer 2.1.

**DESIGN**

CGW is a secure, *n*-tiered application. A web browser submits requests to application servers that persist data in a relational database. CGW utilizes Grail and Groovy, permitting advanced, automated, and customized access to the application\'s features. RedHat MRG is used to launch and track complex analysis pipelines.

**RESULTS**

CGW is used by Washington University Genomic and Pathology Services for clinical genomic testing of many cancers. Orders are accessioned in CoPath and subsequently, the CGW. DNA from specimens is subjected to NextGen sequencing, which is tracked in the CGW. Informatics pipelines for variant detection are executed from the CGW once the sequencing run completes. Results are loaded into the CGW database following analysis completion. Called variants are viewed in context of data from other variant databases such as dbSNP, COSMIC, HGMD, and ClinVar, and previously curated interpretations for variants are automatically inserted into a draft clinical report. The draft report is reviewed and finalized by the clinical genomicist and messaged to the medical record for persistence. CGW has been used to sign out over 100 cases since November 2011, and more than 2000 cases are expected to be signed off by June 2013. There are 22 ordering oncologists and 7 clinical genomicists that use the CGW. Future plans include increasing the number of comprehensive cancer panel genes from 27 to 50 and introducing test panels for drug metabolism and transport, renal, and cardiac diseases. Finally, CGW is in the process of being adopted at several other clinical genomic laboratories nationally and globally.

**CONCLUSION**

CGW is a "soup-to-nuts" software solution for managing clinical genomic testing through order intake, sequencing, analysis, case review, interpretation, and reporting.

Development of Automated Testing Solution for Anatomic Pathology Laboratory Information System: Background, Technical Design, and Future Vision

**J. Mark Tuthill^1^, Ron Brown^1^, Jennifer Lyle^2^, Chris Gardenhour**

^1^Division of Pathology Informatics, Department of Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, MI, ^2^Software Testing Solutions, Tucson, AZ. E-mail: <mtuthil1@hrhs.org>

**CONTENT**

We have previously reported on use of an automated testing solution for clinical pathology CLIA validation testing. Working with our vendor partners, we developed a novel testing solution to support validation testing of our CoPathPlus Laboratory Information System (LIS), specifically for the surgical pathology cases. Although validation testing is less complex for anatomic pathology laboratory information system (AP-LIS), functional testing is becoming increasingly complicated as AP-LIS increase in sophistication.

**TECHNOLOGY**

AP-LIS: Sunquest CoPathPlus 6.0 (Sunquest Information Systems, Tucson, AZ); STS Workstation, 1 Dell Optiplex 745 (Dell, Roundrock, TX, USA) running Microsoft Windows XP; STS™ Lab Volume and Scenario Solutions (Software Testing Solutions™, Tucson, AZ, USA); Remote Connection: PC Anywhere v11.5 (Symantec™, Cupertino, CA, USA).

**DESIGN**

Working with STS, their software was adapted to validate aspects of the CoPathPlus 6.0 AP-LIS. Specifically, the system will automatically accession cases across all specimen classes inserting all part types and quick text in that specimen class. Further, the system will automatically and iteratively order all available stains, stain protocols, and procedures using a specified number of accessions. If a stain has been previously used in a protocol, it will skip to the next stain in the dictionary. All cases are automatically signed out and transmitted across the HL7 interface. The design leverages all rules system configurations built in the AP-LIS. For example, a quick text associated with a part type will be used preferentially to random quick text. The system can be uniquely configured to test workflow at different sites.

**RESULTS**

Although the system is very useful for validation of results in a receiving system by generating a large amount of outbound data, a more important benefit is assessment of functionality of AP-LIS. Since the system leverages rules within the AP-LIS, secondary events are generated that can be difficult to test in a manual fashion. All of the cases signed out automatically in STS also generate events such as billing data, slide label, cassette printing, and transactions to interfaced systems such as auto-stainers. Manually, this would take weeks to actualize; as STS is automated, we can perform the same testing for every part type, stain protocol, and procedure with all secondary events in less than 48 h with using the least possible number of accession numbers.

**CONCLUSION**

Automation of AP-LIS validation testing can provide significant benefits both in terms of validation testing as well as system functional testing. The solution will continue to be developed and enhanced to be applied to cytopathology testing.
